The latest market sizing information for the year 2023, forecasted until 2032, is now incorporated in The Business Research Company’s global market reports.

 As indicated by The Business Research Company’s Naloxone Spray Global Market Report 2023, the global size of the naloxone spray market increased from $433.66 million in 2022 to $531.58 million in 2023, achieving a compound annual growth rate (CAGR) of 22.6%. The naloxone spray market is projected to expand to $1221.6 million by 2027, with a CAGR of 23.1%.

 In the year 2022, North America seized the largest share of the naloxone spray market.

Naloxone Spray Market Driver
The increase in the prevalence of opioid overdoses significantly contributes to the expansion of the naloxone spray market. Opioids, including medications like morphine, fentanyl, and tramadol, are used to manage pain. Nevertheless, due to their pharmacological effects, misuse, prolonged use, non-medical usage, and use without medical oversight can lead to opioid dependency, respiratory issues, or even fatality and other health concerns. For example, a report published by the Centers for Disease Control and Prevention (CDC) in February 2021 revealed that opioids were implicated in 49,860 overdose deaths (representing 70.6% of total drug overdose deaths). According to the World Health Organization (WHO), as of 2020, more than 70% of deaths related to opioids, and within this, 30% of deaths result from overdoses. Naloxone nasal spray is utilized as an emergency medical treatment to counteract the life-threatening effects of an opiate or opioid overdose. Thus, the escalating prevalence of opioid overdoses propels the growth of the naloxone spray market.

View More On The Naloxone Spray Market Report 2023 – https://www.thebusinessresearchcompany.com/report/naloxone-spray-global-market-report

Prominent Trend in the Naloxone Spray Market
The rise in product approvals plays a pivotal role in shaping the naloxone spray market. Key manufacturers of naloxone sprays are focusing on obtaining new product approvals to broaden their product portfolios and enhance their presence in the naloxone spray sector. For instance, in April 2021, the US Food and Drug Administration (FDA) granted approval for Hikma Pharmaceuticals KLOXXADOTM (naloxone hydrochloride) nasal spray 8mg, intended for the immediate treatment of recognized or suspected opioid overdose, demonstrated through respiratory and/or central nervous system depression, in adult and pediatric patients. KLOXXADOTM presents a significant advancement in treating the opioid epidemic, containing twice the amount of naloxone per spray compared to Narcan Nasal Spray 4mg. This ready-to-use nasal spray effectively reverses the effects of opioid overdose.

Key Players in the Naloxone Spray Market
Prominent participants in the naloxone spray market encompass Emergent BioSolutions, Pfizer, Teva Pharmaceutical Industries Ltd., Opiant Pharmaceuticals, Hikma Pharmaceuticals, Nasus Pharma, Amphastar Pharmaceuticals, Indivior PLC, Samarth Pharma Pvt. Ltd., Troikaa Pharmaceuticals Ltd., and Neon Laboratories Limited.

Request A Sample Of The Global Naloxone Spray Market Report 2023:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5339&type=smp

Key Naloxone Spray Market Segments
1) By Dosage: 2 mg/Actuation, 4 mg/Actuation
2) By Distribution Channel: Hospitals, Clinics, Retail Pharmacies, Online Pharmacies, Other distribution channels

The Naloxone Spray Global Market Report 2023  offers a comprehensive overview of the naloxone spray market size, trends, drivers, opportunities, strategies, and companies analysis. The countries covered in the report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, along with the seven major regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

View More Related Reports –
Nasal Splints Global Market Report 2023
Nasal Polyps Treatment Global Market Report 2023
Pharmaceutical Drugs Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model